Author | Year | Region | Risk allele frequency | P-value | |
---|---|---|---|---|---|
T2DM | Control | ||||
Xiao et al14 | 2016 | China | 0.31 | 0.28 | 0.014 |
Votsi et al15 | 2017 | Cyprus | 0.41 | - | 0.006 |
Rong et al16 | 2009 | USA | 0.15 | 0.14 | 0.800 |
Hotta et al18 | 2011 | Japan | 0.40 | 0.45 | 0.000 |
Ramya et al19 | 2012 | India | 0.14 | 0.11 | <0.0001 |
Chauhan et al20 | 2011 | India | 0.35 | 0.34 | 0.36 |
Vatankhah et al26 | 2020 | Iran | 0.76 | 0.74 | 0.132 |
Bego et al27 | 2019 | West Balkan | 0.50 | 0.46 | 0.659 |
Almawi et al28 | 2013 | Lebanon | 0.49 | 0.55 | - |
Al-Sinani et al29 | 2015 | Oman | 0.46 | 0.43 | 0.770 |
Nikitin et al30 | 2017 | Russia | 067 | 0.67 | 0.100 |
Gamboa et al31 | 2012 | Mexico | 0.19 | 0.2 | 0.278 |
van Herpt et al32 | 2017 | Netherlands | 0.41 | 0.38 | 0.45 |
Xiao et al37 | 2015 | China | 0.31 | 0.27 | 0.027 |
FTO: fat mass and obesity-associated, T2DM:n type 2 diabetes mellitus